Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.

about

Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.

Item

http://www.wikidata.org/entity/Q47190014

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Robust vascular invasion concu ...... node-negative gastric cancer.

@en

Robust vascular invasion concu ...... node-negative gastric cancer.

@nl

type

Item

label

Robust vascular invasion concu ...... node-negative gastric cancer.

@en

Robust vascular invasion concu ...... node-negative gastric cancer.

@nl

prefLabel

Robust vascular invasion concu ...... node-negative gastric cancer.

@en

Robust vascular invasion concu ...... node-negative gastric cancer.

@nl

P1476

Robust vascular invasion concu ...... node-negative gastric cancer.

@en

P2093

Akira Ema

http://www.w3.org/2001/XMLSchema#string

Hiroaki Mieno

http://www.w3.org/2001/XMLSchema#string

Hiromitsu Moriya

http://www.w3.org/2001/XMLSchema#string

Ippeita Araki

http://www.w3.org/2001/XMLSchema#string

Keishi Yamashita

http://www.w3.org/2001/XMLSchema#string

Marie Washio

http://www.w3.org/2001/XMLSchema#string

Masahiko Watanabe

http://www.w3.org/2001/XMLSchema#string

Natsuya Katada

http://www.w3.org/2001/XMLSchema#string

Shiro Kikuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer.

Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.

Trend in gastric cancer: 35 years of surgical experience in Japan.

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.

Laparoscopy versus open distal gastrectomy by expert surgeons for early gastric cancer in Japanese patients: short-term clinical outcomes of a randomized clinical trial.

Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.

P304

478-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00595-017-1611-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kei Hosoda

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29256147

http://www.w3.org/2001/XMLSchema#string